Stay updated on ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page. This does not reflect a substantive change to study details or content.
    Difference
    0.0%
    Check dated 2026-07-25T12:57:23.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Added a publication citation (Horinouchi et al.) to the study Publications section describing a phase Ib study of telisotuzumab vedotin with osimertinib in c-Met–expressing NSCLC, and updated the revision tag from v3.6.2 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:31.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a recent site version update.
    Difference
    0.0%
    Check dated 2026-06-27T00:30:25.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    New user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated. The page now includes the recruitment status note 'No longer looking for participants' and records Revision: v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T16:50:59.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a minor site/software update rather than a change to study data. No changes to the study details, locations, or eligibility information are implied by this revision.
    Difference
    0.0%
    Check dated 2026-06-05T13:34:12.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed, signaling a site version update in the header/footer. This update appears to be administrative and does not modify the study page content.
    Difference
    0.0%
    Check dated 2026-05-15T06:22:36.000Z thumbnail image

Stay in the know with updates to ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.